Genoptix ranked #41 on Deloitte's Technology Fast 500

Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced that it ranked number 41 on Technology Fast 500™, Deloitte's ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on percentage of fiscal year revenue growth during the five year period from 2005–2009. Genoptix grew 3,451 percent during this period.

Tina S. Nova, Ph.D., President and CEO of Genoptix, credits their specialized, physician-directed approach to testing and diagnosis with the company's revenue growth.  "We are honored to rank among the top 50 fastest-growing technology companies in North America for the third year in a row based on our performance from 2005 to 2009," said Dr. Nova.  "We have grown by focusing on the needs of community-based hematologists and oncologists and by adapting to a continually changing environment, and this recognition is a testament to the exceptional execution of the entire Genoptix team."

"Genoptix, Inc. and the other 2010 Technology Fast 500™ winners forged ahead in a challenging economic environment to realize exceptional growth," said Phil Asmundson, vice chairman and Deloitte's U.S. technology, media and telecommunications leader. "Deloitte commends Genoptix for this impressive accomplishment."

In addition, Genoptix was ranked the second fastest-growing company in the San Diego region, according to the Technology Fast 500. Overall, Technology Fast 500™ award winners for 2010 had revenue growth ranging from 146 percent to 164,079 percent from 2005 to 2009, with an average growth of 2,361 percent.

"Genoptix has proved itself to be one of the fastest growing companies in North America, and we are proud to honor them as one of the 2010 Technology Fast 500™," said Mark Jensen, managing partner, venture capital services, Deloitte & Touche LLP.